These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Growth and survival mechanisms associated with perineural invasion in prostate cancer. Ayala GE; Dai H; Ittmann M; Li R; Powell M; Frolov A; Wheeler TM; Thompson TC; Rowley D Cancer Res; 2004 Sep; 64(17):6082-90. PubMed ID: 15342391 [TBL] [Abstract][Full Text] [Related]
23. Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation. Tse AK; Wan CK; Shen XL; Yang M; Fong WF Biochem Pharmacol; 2005 Nov; 70(10):1443-57. PubMed ID: 16181613 [TBL] [Abstract][Full Text] [Related]
24. Up-regulation of CXCR4 expression in PC-3 cells by stromal-derived factor-1alpha (CXCL12) increases endothelial adhesion and transendothelial migration: role of MEK/ERK signaling pathway-dependent NF-kappaB activation. Kukreja P; Abdel-Mageed AB; Mondal D; Liu K; Agrawal KC Cancer Res; 2005 Nov; 65(21):9891-8. PubMed ID: 16267013 [TBL] [Abstract][Full Text] [Related]
25. Intracellular inhibitory effects of Velcade correlate with morphoproteomic expression of phosphorylated-nuclear factor-kappaB and p53 in breast cancer cell lines. Lun M; Zhang PL; Siegelmann-Danieli N; Blasick TM; Brown RE Ann Clin Lab Sci; 2005; 35(1):15-24. PubMed ID: 15830705 [TBL] [Abstract][Full Text] [Related]
26. Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model. Narayanan BA; Narayanan NK; Pittman B; Reddy BS Clin Cancer Res; 2004 Nov; 10(22):7727-37. PubMed ID: 15570007 [TBL] [Abstract][Full Text] [Related]
27. Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis. Huerta-Yepez S; Vega M; Garban H; Bonavida B Clin Immunol; 2006 Sep; 120(3):297-309. PubMed ID: 16784892 [TBL] [Abstract][Full Text] [Related]
28. Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinoma. Jackson-Bernitsas DG; Ichikawa H; Takada Y; Myers JN; Lin XL; Darnay BG; Chaturvedi MM; Aggarwal BB Oncogene; 2007 Mar; 26(10):1385-97. PubMed ID: 16953224 [TBL] [Abstract][Full Text] [Related]
29. Inhibition of nuclear translocation of nuclear factor-{kappa}B contributes to 3,3'-diindolylmethane-induced apoptosis in breast cancer cells. Rahman KW; Sarkar FH Cancer Res; 2005 Jan; 65(1):364-71. PubMed ID: 15665315 [TBL] [Abstract][Full Text] [Related]
30. Activation of nuclear factor-kappa B is linked to resistance to neoadjuvant chemotherapy in breast cancer patients. Montagut C; Tusquets I; Ferrer B; Corominas JM; Bellosillo B; Campas C; Suarez M; Fabregat X; Campo E; Gascon P; Serrano S; Fernandez PL; Rovira A; Albanell J Endocr Relat Cancer; 2006 Jun; 13(2):607-16. PubMed ID: 16728586 [TBL] [Abstract][Full Text] [Related]
32. Parthenolide, a natural inhibitor of Nuclear Factor-kappaB, inhibits lung colonization of murine osteosarcoma cells. Kishida Y; Yoshikawa H; Myoui A Clin Cancer Res; 2007 Jan; 13(1):59-67. PubMed ID: 17200339 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of transcription factor NF-kappaB signaling proteins IKKbeta and p65 through specific cysteine residues by epoxyquinone A monomer: correlation with its anti-cancer cell growth activity. Liang MC; Bardhan S; Pace EA; Rosman D; Beutler JA; Porco JA; Gilmore TD Biochem Pharmacol; 2006 Feb; 71(5):634-45. PubMed ID: 16360644 [TBL] [Abstract][Full Text] [Related]
34. Down-regulation of CD9 expression during prostate carcinoma progression is associated with CD9 mRNA modifications. Wang JC; Bégin LR; Bérubé NG; Chevalier S; Aprikian AG; Gourdeau H; Chevrette M Clin Cancer Res; 2007 Apr; 13(8):2354-61. PubMed ID: 17406028 [TBL] [Abstract][Full Text] [Related]
35. Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappaB/p65 DNA binding. Hu J; Colburn NH Mol Cancer Res; 2005 Feb; 3(2):100-9. PubMed ID: 15755876 [TBL] [Abstract][Full Text] [Related]
36. Nuclear factor-kappaB-dependent mechanisms in breast cancer cells regulate tumor burden and osteolysis in bone. Gordon AH; O'Keefe RJ; Schwarz EM; Rosier RN; Puzas JE Cancer Res; 2005 Apr; 65(8):3209-17. PubMed ID: 15833852 [TBL] [Abstract][Full Text] [Related]
37. Constitutive NF-kappaB activation in colorectal carcinoma plays a key role in angiogenesis, promoting tumor growth. Sakamoto K; Maeda S; Hikiba Y; Nakagawa H; Hayakawa Y; Shibata W; Yanai A; Ogura K; Omata M Clin Cancer Res; 2009 Apr; 15(7):2248-58. PubMed ID: 19276252 [TBL] [Abstract][Full Text] [Related]
38. Differentiation of androgen-independent prostate cancer PC-3 cells is associated with increased nuclear factor-kappaB activity. Floryk D; Huberman E Cancer Res; 2005 Dec; 65(24):11588-96. PubMed ID: 16357169 [TBL] [Abstract][Full Text] [Related]
39. Curcumin sensitizes human colorectal cancer xenografts in nude mice to gamma-radiation by targeting nuclear factor-kappaB-regulated gene products. Kunnumakkara AB; Diagaradjane P; Guha S; Deorukhkar A; Shentu S; Aggarwal BB; Krishnan S Clin Cancer Res; 2008 Apr; 14(7):2128-36. PubMed ID: 18381954 [TBL] [Abstract][Full Text] [Related]
40. The significance of LMO2 expression in the progression of prostate cancer. Ma S; Guan XY; Beh PS; Wong KY; Chan YP; Yuen HF; Vielkind J; Chan KW J Pathol; 2007 Feb; 211(3):278-85. PubMed ID: 17167821 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]